Insider: Garg Pushkal EVP Chief R&D - ALNYLAM PHARMACEUTICALS, INC.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 21,400 | 0 | 21,400 |
| Value | $9,552,960.00 | $0.00 | $9,552,960.00 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 08/19/2025 | DDS | 276 | Direct | COM | $455.41 | $125,693.16 | 21,400 |
| 08/19/2025 | DDS | 45 | Direct | COM | $461.74 | $20,778.30 | 20,221 |
| 08/19/2025 | DDS | 231 | Direct | COM | $458.27 | $105,860.37 | 20,831 |
| 08/19/2025 | DDS | 338 | Direct | COM | $457.26 | $154,553.88 | 21,062 |
| 08/19/2025 | DDS | 260 | Direct | COM | $459.59 | $119,493.40 | 20,571 |
| 08/19/2025 | DDS | 305 | Direct | COM | $461.01 | $140,608.05 | 20,266 |
| 08/18/2025 | DDS | 39 | Direct | COM | $450.92 | $17,585.88 | 22,904 |
| 08/18/2025 | DDS | 39 | Direct | COM | $447.98 | $17,471.22 | 23,033 |
| 08/18/2025 | DDS | 103 | Direct | COM | $451.99 | $46,554.97 | 22,801 |
| 08/18/2025 | DDS | 90 | Direct | COM | $449.92 | $40,492.80 | 22,943 |
| 08/18/2025 | DDS | 329 | Direct | COM | $452.96 | $149,023.84 | 22,472 |
| 08/18/2025 | DDS | 12 | Direct | COM | $455.82 | $5,469.84 | 21,676 |
| 08/18/2025 | DDS | 241 | Direct | COM | $454.84 | $109,616.44 | 21,688 |
| 08/18/2025 | DDS | 543 | Direct | COM | $454.04 | $246,543.72 | 21,929 |
| 03/24/2025 | DDS | 5,445 | Direct | COM | $300.00 | $1,633,500.00 | 20,221 |
| 03/21/2025 | DDS | 4,321 | Direct | COM | $285.00 | $1,231,485.00 | 20,221 |
| 03/04/2025 | DDS | 343 | Direct | COM | $240.92 | $82,635.56 | 24,860 |
| 03/04/2025 | DDS | 147 | Direct | COM | $239.25 | $35,169.75 | 25,203 |
| 03/04/2025 | DDS | 198 | Direct | COM | $241.60 | $47,836.80 | 24,662 |
| 03/04/2025 | DDS | 120 | Direct | COM | $242.70 | $29,124.00 | 24,542 |
| 03/03/2025 | DDS | 116 | Direct | COM | $245.26 | $28,450.16 | 26,377 |
| 03/03/2025 | DDS | 158 | Direct | COM | $244.41 | $38,616.78 | 26,493 |
| 03/03/2025 | DDS | 213 | Direct | COM | $242.37 | $51,624.81 | 26,886 |
| 03/03/2025 | DDS | 48 | Direct | COM | $246.18 | $11,816.64 | 26,329 |
| 03/03/2025 | DDS | 235 | Direct | COM | $243.36 | $57,189.60 | 26,651 |
| 1 2 3 4 5 Next Last You are at page 1 of 5 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research